Data di Pubblicazione:
2016
Citazione:
Effects of rituximab in connective tissue disorders related interstitial lung disease / Lepri, Gemma; Avouac, Jerome; Airò, Paolo; Anguita Santos, Francisco; BELLANDO RANDONE, Silvia; Blagojevic, Jelena; Garcia Hernàndez, Francisco; Gonzalez Nieto, Jose Antonio; Guiducci, Serena; Jordan, Suzana; Limaye, Vidya; Maurer, Britta; Selva O'Callaghan, Albert; Riccieri, Valeria; Distler, Oliver; MATUCCI CERINIC, Marco; Allanore, Yannick. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - 34 Suppl 100:(2016), pp. 181-185.
Abstract:
Interstitial lung disease (ILD) is a key prognostic factor in connective tissue disorders (CTDs). The aim of our study was to assess the changes in pulmonary functional tests (PFTs) in various CTDs, including anti-synthetase syndrome (SYN), systemic sclerosis (SSc) and mixed connective tissue disorder (MCTD), following the use of rituximab therapy.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Systemic Sclerosis; rituximab
Elenco autori:
Lepri, Gemma; Avouac, Jerome; Airò, Paolo; Anguita Santos, Francisco; BELLANDO RANDONE, Silvia; Blagojevic, Jelena; Garcia Hernàndez, Francisco; Gonzalez Nieto, Jose Antonio; Guiducci, Serena; Jordan, Suzana; Limaye, Vidya; Maurer, Britta; Selva O'Callaghan, Albert; Riccieri, Valeria; Distler, Oliver; MATUCCI CERINIC, Marco; Allanore, Yannick
Link alla scheda completa:
Pubblicato in: